Anthranilic Acid

Anthranilic Acid

SCHEMBL2961107

Nc1ccccc1C(=O)O.Nc1ccccc1C(=O)O.Nc1ccccc1C(=O)O.Nc1ccccc1C(=O)O.Nc1ccccc1C(=O)O.Nc1ccccc1C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
ALOX15 P16050 1/20 0.65
MAPT P10636 5/20 0.64
GAA P10253 1/20 0.64
MMP2 P08253 1/20 0.64
HSD17B10 Q99714 3/20 0.56
IDO1 P14902 1/20 0.56
CFTR P13569 1/20 0.56
KDM4E B2RXH2 5/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
HMGB1 P09429 1/20 0.54
HPGD P15428 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA7 P43166 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CA9 Q16790 1/20 0.54
NAPRT Q6XQN6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthranilic Acid SCHEMBL29365173 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL3110791 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL362171 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL29802554 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL2953168 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL675 1.00 ALDH1A1 (0.65) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL16107607 0.97 ALDH1A1 (0.62) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL11130666 0.97 ALDH1A1 (0.62) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL1424090 0.97 ALDH1A1 (0.62) ALDH1A1ALOX15MAPTGAAMMP2
Anthranilic Acid SCHEMBL1282042 0.97 ALDH1A1 (0.62) ALDH1A1ALOX15MAPTGAAMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754862-B2 Multi-chromophoric AZO pyridone colorants XEROX CORPORATION (US) 2010-07-13 US disclosed
US-7381253-B2 Multi-chromophoric azo pyridone colorants XEROX CORPORATION (US) 2008-06-03 US disclosed
US-20080071051-A1 MULTI-CHROMOPHORIC AZO PYRIDONE COLORANTS XEROX CORPORATION (US) 2008-03-20 US disclosed
US-20060117991-A1 Phase change inks; piezoelectric printing XEROX CORPORATION 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060117991-A1 Phase change inks; piezoelectric printing RB1, CDKN1A, RCC1 ALDH1A1 3706/4885ALOX15 4774/4885MAPT 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.